BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10707134)

  • 1. Ocular toxicity in low-dose tamoxifen: a prospective study.
    Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
    Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
    Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinal changes associated with tamoxifen treatment for breast cancer.
    Tang R; Shields J; Schiffman J; Li H; Locher D; Hampton J; Prager T; Pardo G
    Eye (Lond); 1997; 11 ( Pt 3)():295-7. PubMed ID: 9373465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen and ocular toxicity.
    Ah-Song R; Sasco AJ
    Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocal electroretinography, color discrimination and ocular toxicity in tamoxifen use.
    Salomão SR; Watanabe SE; Berezovsky A; Motono M
    Curr Eye Res; 2007 Apr; 32(4):345-52. PubMed ID: 17453956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-associated eye disease. A review.
    Nayfield SG; Gorin MB
    J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for tamoxifen ocular toxicity: a prospective study.
    Therssen R; Jansen E; Leys A; Rutten J; Meyskens J
    Eur J Ophthalmol; 1995; 5(4):230-4. PubMed ID: 8963159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular toxicity of tamoxifen.
    Gerner EW
    Ann Ophthalmol; 1989 Nov; 21(11):420-3. PubMed ID: 2619152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and in vivo confocal microscopy findings in patients receiving tamoxifen citrate.
    Muftuoglu O; Uçakhan OO; Kanpolat A
    Eye Contact Lens; 2006 Sep; 32(5):228-32. PubMed ID: 16974155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystalline maculopathy: a rare complication of tamoxifen therapy.
    Srikantia N; Mukesh S; Krishnaswamy M
    J Cancer Res Ther; 2010; 6(3):313-5. PubMed ID: 21119261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen keratopathy as seen with in-vivo confocal microscopy.
    Tarafdar S; Lim LT; Collins CE; Ramaesh K
    Semin Ophthalmol; 2012; 27(1-2):27-8. PubMed ID: 22352823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
    Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
    J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term tamoxifen citrate use and potential ocular toxicity.
    Gorin MB; Day R; Costantino JP; Fisher B; Redmond CK; Wickerham L; Gomolin JE; Margolese RG; Mathen MK; Bowman DM; Kaufman DI; Dimitrov NV; Singerman LJ; Bornstein R; Wolmark N
    Am J Ophthalmol; 1998 Apr; 125(4):493-501. PubMed ID: 9559735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients.
    Pavlidis NA; Petris C; Briassoulis E; Klouvas G; Psilas C; Rempapis J; Petroutsos G
    Cancer; 1992 Jun; 69(12):2961-4. PubMed ID: 1591689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen-induced ocular toxicity.
    Mihm LM; Barton TL
    Ann Pharmacother; 1994 Jun; 28(6):740-2. PubMed ID: 7919565
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen retinopathy: does it really exist?
    Lazzaroni F; Scorolli L; Pizzoleo CF; Savini G; De Nigris A; Giosa F; Meduri RA
    Graefes Arch Clin Exp Ophthalmol; 1998 Sep; 236(9):669-73. PubMed ID: 9782427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
    Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
    Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular assessment of patients treated with tamoxifen.
    Beck M; Mills PV
    Cancer Treat Rep; 1979; 63(11-12):1833-4. PubMed ID: 526917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cysts in tamoxifen-treated women with breast cancer.
    Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
    Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.